0001127602-21-025686.txt : 20210922
0001127602-21-025686.hdr.sgml : 20210922
20210922161541
ACCESSION NUMBER: 0001127602-21-025686
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210920
FILED AS OF DATE: 20210922
DATE AS OF CHANGE: 20210922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McKee Amy E
CENTRAL INDEX KEY: 0001883764
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 211269801
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BLVD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-09-20
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001883764
McKee Amy E
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Non-Qualified Stock Option
15.02
2021-09-20
4
A
0
53333
0
A
2031-09-20
Common Stock
53333
53333
D
Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan.
The option vests 1/36 per month for a period of 36 months, beginning on October 20, 2021
/s/ Jessica Dickerson, by power of attorney
2021-09-22